Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Soluble PD-L1: a potential dynamic predictive biomarker for immunotherapy in patients with proficient mismatch repair colorectal cancer
Yinjun He, Xiang Zhang, Ming Zhu, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 16

Showing 16 citing articles:

Prognostic value of soluble PD-L1 and exosomal PD-L1 in advanced gastric cancer patients receiving systemic chemotherapy
Kabsoo Shin, Joori Kim, Se Jun Park, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 24
Advances in Precision Medicine Approaches for Colorectal Cancer: From Molecular Profiling to Targeted Therapies
Neelakanta Sarvashiva Kiran, Chandrashekar Yashaswini, Rahul Maheshwari, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 4, pp. 967-990
Open Access | Times Cited: 15
New insights into immune cells in cancer immunotherapy: from epigenetic modification, metabolic modulation to cell communication
Sha Qin, Bin Xie, Qingyi Wang, et al.
MedComm (2024) Vol. 5, Iss. 6
Open Access | Times Cited: 10
Soluble B7 and TNF family in colorectal cancer: Serum level, prognostic and treatment value
Mina Monfared, Sina Nazmi, Forough Parhizkar, et al.
Human Immunology (2025) Vol. 86, Iss. 2, pp. 111232-111232
Closed Access | Times Cited: 1
Network approach in liquidomics landscape
Daniele Santini, Andrea Botticelli, Antonio Galvano, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 21
Soluble PD-L1: From Immune Evasion to Cancer Therapy
Laura Denisa Dragu, Laura Georgiana Necula, Coralia Bleoţu, et al.
Life (2025) Vol. 15, Iss. 4, pp. 626-626
Open Access
Soluble immune checkpoint molecules in cancer risk, outcomes prediction, and therapeutic applications
Lin Chen, Yuqing Chao, Wenjing Li, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 4
Assessing the Clinical Relevance of Soluble PD-1 and PD-L1: A Multi-Cohort Study Across Diverse Tumor Types and Prognostic Implications
Nikolay E. Kushlinskii, О. В. Ковалева, Alexei Gratchev, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 500-500
Open Access
Variation of peripheral blood-based biomarkers for response of anti-PD-1 immunotherapy in non-small-cell lung cancer
Xiaoming Wang, Dayu Chen, Yuyan Ma, et al.
Clinical & Translational Oncology (2024) Vol. 26, Iss. 8, pp. 1934-1943
Open Access | Times Cited: 3
Serum sPD‐1 and sPD‐L1 as predictive biomarkers for HBsAg clearance in HBeAg‐negative CHB patients undergoing IFN‐based therapy
Xiyao Chen, Boxiang Zhang, Xin Song, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 60, Iss. 5, pp. 593-603
Closed Access | Times Cited: 3
Protein isoform-centric therapeutics: expanding targets and increasing specificity
Peter Kjer-Hansen, Tri Giang Phan, Robert J. Weatheritt
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 10, pp. 759-779
Closed Access | Times Cited: 3
Low plasma PD-L1 levels, early tumor onset and absence of peritoneal carcinomatosis improve prognosis of women with advanced high-grade serous ovarian cancer
Daniele Fanale, Chiara Brando, Lidia Rita Corsini, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 8
Missing prognostic value of soluble PD-1, PD-L1 and PD-L2 in lung cancer patients undergoing chemotherapy – A CEPAC-TDM biomarker substudy
Kimberly Geiger, Markus Joerger, Max Roessler, et al.
Tumor Biology (2024) Vol. 46, Iss. s1, pp. S355-S367
Open Access | Times Cited: 1
Label Free Detection of Programmed Death Ligand 1 Protein Biomarker by Quartz Tuning Fork-Based Biosensor
Mahmoud Al‐Gawati, Qura Tul Ain, Khalid E. Alzahrani, et al.
Journal of The Electrochemical Society (2023) Vol. 170, Iss. 12, pp. 127511-127511
Closed Access | Times Cited: 3
Evaluation of PD-L1 Expression in Colorectal Carcinomas by Comparing Scoring Methods and Their Significance in Relation to Clinicopathologic Parameters
Mirela Frančina, Mislav Mikuš, Marin Mamić, et al.
Diagnostics (2024) Vol. 14, Iss. 10, pp. 1007-1007
Open Access
Variation of Peripheral Blood-based Biomarkers for Response of Anti-PD-1 Immunotherapy in Lung Cancer
Feng Yan, Xiaoming Wang, Dayu Chen, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top